Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1981 Jun;19(6):1029–1031. doi: 10.1128/aac.19.6.1029

Pharmacokinetics of netilmicin in children with and without cystic fibrosis.

H Michalsen, T Bergan
PMCID: PMC181602  PMID: 7271272

Abstract

The pharmacokinetics of intravenous netilmicin was studied in cystic fibrosis (CF) and non-CF patients who were closely matched according to age. The serum concentrations showed a moderately higher variance within the CF group. The serum half-life in CF patients was 1.37 h compared with 2.29 h in the non-CF subjects (P less than 0.05). The apparent distribution coefficients were 0.306 and 0.356 liters/kg in the CF and non-CF groups, respectively. The mean body clearance was 6.6 liters/h per 1.73 m2 in the CF group compared with 5.3 liters/h per m2 in the non-CF controls, but the difference was not significant. The mean renal clearance in CF patients was 4.7 liters/h per 1.73 m2. From a pharmacokinetic point of view, the dosage of netilmicin required may be the same in CF as in non-CF patients.

Full text

PDF
1029

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bergan T., Michalsen H. Pharmacokinetics of azlocillin in children with cystic fibrosis. Arzneimittelforschung. 1979;29(12A):1955–1957. [PubMed] [Google Scholar]
  2. Chiu P. J., Miller G. H., Brown A. D., Long J. F., Waitz J. A. Renal pharmacology of netilmicin. Antimicrob Agents Chemother. 1977 May;11(5):821–825. doi: 10.1128/aac.11.5.821. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Finkelstein E., Hall K. Aminoglycoside clearance in patients with cystic fibrosis. J Pediatr. 1979 Jan;94(1):163–164. doi: 10.1016/s0022-3476(79)80394-7. [DOI] [PubMed] [Google Scholar]
  4. Guggenbichler J. P., Kienel G. Bioavailability of oral antibiotics in cystic fibrosis. Monogr Paediatr. 1979;10:34–40. [PubMed] [Google Scholar]
  5. Jusko W. J., Mosovich L. L., Gerbracht L. M., Mattar M. E., Yaffe S. J. Enhanced renal excretion of dicloxacillin in patients with cystic fibrosis. Pediatrics. 1975 Dec;56(6):1038–1044. [PubMed] [Google Scholar]
  6. Meyers B. R., Hirschman S. Z., Wormser G., Siegel D. Pharmacokinetic study of netilmicin. Antimicrob Agents Chemother. 1977 Jul;12(1):122–123. doi: 10.1128/aac.12.1.122. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Pechere J. C., Dugal R., Pechere M. M. Kinetics of netilmicin in man. Clin Pharmacol Ther. 1978 Jun;23(6):677–684. doi: 10.1002/cpt1978236677. [DOI] [PubMed] [Google Scholar]
  8. Wenk M., Spring P., Vozeh S., Follath F. Multicompartment pharmacokinetics of netilmicin. Eur J Clin Pharmacol. 1979 Nov;16(5):331–334. doi: 10.1007/BF00605631. [DOI] [PubMed] [Google Scholar]
  9. Yaffe S. J., Gerbracht L. M., Mosovich L. L., Mattar M. E., Danish M., Jusko W. J. Pharmacokinetics of methicillin in patients with cystic fibrosis. J Infect Dis. 1977 May;135(5):828–831. doi: 10.1093/infdis/135.5.828. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES